VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Femoston
Preclinical
Small molecule
Y
Yun Chen
1
Indications
5
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Intrauterine Adhesions
Unknown status
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Intrauterine Adhesions
Preclinical
Unknown status
Clinical
Trials by Indication
[1]
Menopausal Syndrome
2 trials
QXZS in Menopausal Syndrome Based on 16S rRNA Sequencing Technology
Unknown status
·
Y
Yun Chen
·
N/A
·
NCT06143696
·
60 enrolled
Clinical Efficacy of Qingxin Zishen Decoction in Treating Menopausal Syndrome and Neuroendocrine Mechanism of Regulating KNDy Neurons
Completed
·
Y
Yun Chen
·
N/A
·
NCT06132620
·
60 enrolled
Intrauterine Adhesions
1 trial
Efficiency of Amnion Graft to Prevent Intrauterine Adhesions After Hysteroscopic Surgery
Unknown status
·
—
·
N/A
·
NCT02132104
·
208 enrolled
Function
1 trial
Clinical Observation on Kuntai Capsule in Treating Early-onset Ovarian Hypofunction
Unknown status
·
—
·
Phase 4
·
NCT05021094
·
120 enrolled
Intrauterine Adhesion
1 trial
Comparison of Different Doses of Oestrogen Therapy for Preventing Intrauterine Adhesion
Completed
·
—
·
Phase 1/2
·
NCT02726971
·
141 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
5 trial records for Femoston. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Femoston compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Femoston. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Yun Chen company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
Y
Yun Chen
Related News